NFE2L2 and diabetic kidney disease: Mitochondria-targeted antioxidant MitoQ, a mitochondria-specific coenzyme Q10 analog, alleviates podocyte apoptosis and tubular epithelial necrosis in diabetic kidney disease by scavenging mitochondrial ROS and restoring mitophagy via the Nrf2/PINK1 signaling pathway.